Abingworth as of Dec. 31, 2020
Portfolio Holdings for Abingworth
Abingworth holds 15 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 37.9 | $111M | 4.2M | 26.56 | |
| Spruce Bio Common | 14.7 | $43M | 1.8M | 24.03 | |
| Phathom Common (PHAT) | 13.7 | $40M | 1.2M | 33.21 | |
| Soleno Common | 6.8 | $20M | 10M | 1.93 | |
| Verona Sponds Adr (VRNA) | 5.8 | $17M | 2.5M | 6.89 | |
| Nucana Ads (NCNA) | 5.1 | $15M | 3.3M | 4.49 | |
| Sierra Oncology Common | 4.8 | $14M | 871k | 15.96 | |
| Exicure Common | 4.2 | $12M | 7.0M | 1.77 | |
| Sientra Common | 3.2 | $9.3M | 2.4M | 3.89 | |
| Paratek Common | 2.2 | $6.5M | 1.0M | 6.26 | |
| Aeglea Common | 0.6 | $1.9M | 241k | 7.87 | |
| Molecular Templates Common | 0.6 | $1.9M | 200k | 9.42 | |
| Cymabay Common | 0.3 | $752k | 131k | 5.74 | |
| Obseva Common | 0.1 | $182k | 88k | 2.07 | |
| Ocugen Common | 0.0 | $13k | 7.1k | 1.83 |
